Pegulicianine acetate (marketed as Lumisight) is an intravenous, fluorescent imaging agent used during breast-conserving surgery (lumpectomy) to detect remaining cancerous tissue in the surgical cavity. It functions as a tumor-seeking, optical imaging agent that highlights malignant cells, helping surgeons remove more cancer, reducing the need for follow-up surgeries. The directory classifies it as a clinical API with a biotechnology source/manufacturing origin. Other names for this substance include Lumisight and LUM015. Its PubChem SID is 505855085.
Pegulicianine acetate
| CAS No | 2230217-18-0 |
|---|---|
| Molecular Formula | N/A |
| Synonyms | N/A |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pegulicianine acetate (marketed as Lumisight) is an intravenous, fluorescent imaging agent used during breast-conserving surgery (lumpectomy) to detect remaining cancerous tissue in the surgical cavity.
The listed CAS number is 2230217-18-0.
The listed molecular formula is N/A.
N/A.
The source lists Lumisight and LUM015.
It is listed as a clinical API with a biotechnology origin.